CN Patent

CN109922801B — 甲硝唑和巴氯芬的混悬剂和稀释剂

Assigned to Azurity Pharmaceuticals Inc · Expires 2023-07-18 · 3y expired

What this patent protects

公开了甲硝唑或巴氯芬和/或其盐或酯衍生物(例如甲硝唑苯甲酸酯)的混悬剂。所述混悬剂可包含甲硝唑或巴氯芬和/或其盐或酯衍生物、水胶体稳定剂、二甲硅油乳液、缓冲剂(例如柠檬酸钠(二水合物))、防腐剂、增稠剂、甜味剂和水。

USPTO Abstract

公开了甲硝唑或巴氯芬和/或其盐或酯衍生物(例如甲硝唑苯甲酸酯)的混悬剂。所述混悬剂可包含甲硝唑或巴氯芬和/或其盐或酯衍生物、水胶体稳定剂、二甲硅油乳液、缓冲剂(例如柠檬酸钠(二水合物))、防腐剂、增稠剂、甜味剂和水。

Drugs covered by this patent

Patent Metadata

Patent number
CN109922801B
Jurisdiction
CN
Classification
—
Expires
2023-07-18
Drug substance claim
No
Drug product claim
No
Assignee
Azurity Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.